Open company graph database — free web & API
Login

Shanghai Henlius Biotech, Inc.

上海ヘンリウスバイオテック株式会社Alias
Ticker
—
Listed market
—
Country
China
Employees (non-consolidated)
4,000
Related companies
0
§01

Basic information

BASIC
Head office
11/F, B8 Building, No.188 Yizhou Rd, Xuhui District, ShanghaiSources
Chief executive
Sources
Employees (non-consolidated)
4,000 peopleSources
Employees (consolidated)
Start date
2010-01-01Sources
End date
§02

Websites

1 DOMAINS
§03

Business

11
oncology therapiesSourcesautoimmune disease therapiesSourcesophthalmic disease therapiesSourcesbiosimilar productsSourcesimmune checkpoint inhibitorsSourcesimmune cell engager technologiesSourcesantibody-drug conjugates (ADCs)SourcesAI-enabled early discovery platformsSourcesclinical trialsSourcesbiologics manufacturingSourcesglobal supply systemSources
§04

Related companies

0 COMPANIES

—

§05

Network

NETWORK
Drag to move · click to open
§06

History

3 EVENTS

Obtained approval from the Hong Kong Stock Exchange to officially remove the "B" label from the stock code starting April 23, 2021Sources

In July 2021, the first subject was dosed in a Phase I clinical trial completed in ChinaSources

In October 2025, the SLRU antibody clinical trial in the perioperative period for gastric cancer reached the primary endpoint EFS, supporting early market launchSources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑